medigraphic.com
ISSN 1561-3194 (Electronic)

2012, Number 3

<< Back Next >>

Rev Ciencias Médicas 2012; 16 (3)

Follow-up assessment of women suffering from cervical u terine cancer in two polyclinics, Pinar del Rio

Sanabria NJG, Cruz HIC, Oriolo PL, Pérez HMA, Valdés AB

Language: Spanish
References: 22
Page: 139-160
PDF size: 257.38 Kb.


ABSTRACT

Introduction: Despite of having a program, for a long time, to the early detection of cervical uterine cancer, the results expected are not as far achieved.
Objective: to characterize the patients suffering from invasive cervical uterine cancer in two health areas in Pinar del Rio province throughout five years (2003 -2007).
Material and Methods: observational, cross-sectional, cohort, retrospective study including women at every age with invasive cervical-uterine cancer. The information concerning the patients was collected from the automated records of cervical uterine at the provincial office for cervix pathology treatment (Provincial Public Health Direction), general death rate (Provincial Public Health Direction) and from the clinical histories of the Provincial Cancer Unit. Among the variables studied were: coming or not from the program, age, clinical stage, treatment followed, and a nnual incidence, together with the average of mortality and lethality considering the clinical stages.
Results: 70,6% of the cases were not detected by the program. The average incidence rate was 29.5 per 10 0000 women from 15 years old or older. All pati ents underwent to a specific cancer treatment according to the clinical stage. The greatest mortality rates were found in patients presenting IIIB stage at diagnosis.
Conclusion: errors were observed in Primary Health Care leading to deficiencies in the early detection of this type cancer. The incidence rates of this disease have not diminished; cases suffering from advanced stages of the disease are still detected, shortening the survival rate of these patients.


REFERENCES

  1. Agrawal P. Reducing the burden of cervical cancer in the developing world. Current Women´s Health Reviews feb 2011; 7 (1):59-68. Disponible en: http://www.ingentaconnect.com/content/ben/cwhr/2011/00000007/00000001/art00011 [Access 22-04-11]

  2. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Nat Cancer Inst Monogr 2003;(31):14 -19. Disponible en:http://jncimonographs.oxfordjournals.org/content/2003/31/14.long [Access 25-04- 11]

  3. Tábora N, Ferrera A, Bakkers JMJE, Massuger L FAG, Melchers WJG. High HPV 16 Viral Load is Associated with Increased Cervical Dysplasia in Honduran Women. Am. J. Trop. Med. Hyg., 78(5), 2008, pp. 843 -846 In: http://www.ajtmh.org/conte nt/78/5/843.long [Access 21-12-08]

  4. Alam S, Conway MJ, Chen HS, Meyers C. The cigarette smoke carcinogen benzo a pyrene enhances human papillomavirus synthesis. J Virol 2008 Jan, 82 (2): 1053 -1058. In: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2224 590/. [Access 21-12-08]

  5. Bonassi S, El-Zein R, Bolognesi C, Fenech M. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from humand studies. Mutagenesis 2010; 26 (1): 93-100. In: http://mutage.oxfordjournals.org/content /26/1/93.full [Access: 21-12- 08]

  6. Denis F, Hanz S, Alain S. Clearance, persistence and recurrence of HPV infection. GynecolObstetFertil. 2008 Apr; 36(4):430-40. En: http://www.ncbi.nlm.nih.gov/pubmed/18417407 . [Access 13-06-08]

  7. Monsonego J. Preventi on of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues. Presse Med. 2007 Apr;36(4 Pt 2):640 - 66. In: http://www.ncbi.nlm.nih.gov/pubmed/17350792 . [Access 26-09-2007]

  8. Franco EL, Cuzick J. Cervica l cancer screening following prophylactic human papillomavirus vaccination.Vaccine. 2008 Mar 14;26Suppl 1:A16 -23. In: http://www.sciencedirect.com/science/article/pii/S0264410X07013849 [Access 26-09- 2007]

  9. Arbyn M, Primic-Zakeus M, Raifu AO, Grce M, Para skevaidis E, Diakomanolis E, Kesić V, Nicula FA, Suteu O, von Karsa L. The burden of cervical cancer in south -east Europe at the beginning of the 21st century.CollAntropol. 2007 Apr; 31 Suppl 2:7-10. In: http://www.hrcak.srce.hr/.pdf . [Access: 26-08-07]

  10. Brawley OW. Avoidable cancer deaths globally.CA Cancer J Clin 2011; 61: 67 -68. In: http://onlinelibrary.wiley.com/doi/10.3322/caac.20108/full [Access 14-06-2011.]

  11. MINSAP. Cuba. Programa de Detección Precoz del Cáncer Cérvico -Uterino. 2001.

  12. Flores BP, Volker DL. Cervical cancer screening and older Mexican American women. Res GerontolNurs 2011 Jan; 4 (1): 3 -8. doi: 10.3928/19404921 -20101201-04. In: http://preview.ncbi.nlm.nih.gov/pubmed/21210574 . [Access 30-05-11]

  13. Xi LF, Hughes JP, Cast le PE, Edelstein ZR, Wang C, Galloway DA, Koutsky LA, Kiviat NB, Schiffman M. Viral load in the natural history of HPV Type 16 infection: a Nested case - control study. J InfectDis 2011;203:1425 -33 In: http://www.jid.oxfordjournal.org [Access 16-04-11]

  14. Belinson, J.L., Pretorius, R.G., Zhang, W.H., Wu, L.Y., Qiao, Y.L., and Elson, P. Cervical cancer screening by simple visual inspection after acetic acid. Obstetrics and Gynecology 2001 Sep; 98(3):441 -444. In: http://www.ncbi.nlm.nih.gov/pubmed/11530126 . [Access 22-05-07]

  15. Sanabria NegrinJG, Salgueiro Medina VE, Abreu Mérida MB, Vólquez C. Incremento de la detección de las lesions cervicales por medio del examen visual en Puerto Esperanza, , 2008. Rev Ciencias Médicas [revista en la Internet]. 2011 Sep [citado 2011 Dic 18]; 15(3): 81-98. In: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561 - 31942011000300009&lng=es

  16. Kirschner B, Poll S, Rygaard C, Wåhlin A, Junge J. Screening history in women with cervical cancer in a Danish Popu laton-based screening program.GynecolOncol 2011 Jan, 120 (1): 68-72. In: http://web.ebscohost.com/ehost/21035171 . [Access 15-04-11]

  17. Cantor SB, Cárdenas -Turanzas M, Cox DD, Atkinson EN, Nogueras -González GM, Beck JR, Follen M, Benedet JL. Accuracy of colposcopy in the diagnostic setting compared with the screening setting. ObstetGynecol. 2008 Jan;111(1):7 -14. In: http://www.sggg.ch/files/Garland2007intrabib30004.pdf [Access 01-04-08.]

  18. Castro-Jiménez MA, Londoño-Cuellar PA, Vera-Cala LM. Uso y determinantes del Papsmear en un municipio rural de Colombia 1998 -1999. Rev Salud Pública (Bogotá). 2006 Sep-Dic; 8 (3): 248-57. In: http://www.scielosp.org/scielo.php?pid=S0124 - 00642006000300010&script=sci_arttext&tlng=pt [Access 24-01-07]

  19. Davey DD, Cox JT, Austin RM, Birdsong G, Colgan TJ, Howell LP, Husain M, DarraghTM.Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection. J Low Genit Tract Dis. 2008 Apr ; 12(2):71-81 In: http://journals.lww.com/jlgtd/Abs tract/2008/04000/Cervical_Cytology_Specimen_Adeq uacy__Patient.2.aspx . [Access 26-06-08]

  20. Cucick J Routine audit of large -scale cervical cancer programs. Editorial JNCI; 2008 May 7; 100 (9):604-6. In: http://jnci.oxfordjournals.org/content/100/9/60 5.full [Access 20-07-2008]

  21. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J NatlCancer Inst. 2008 May 7;100 (9):622-9. In: http://jnci.oxfordjournals.org/content/100/9/622.full [Access 25-7-08]

  22. Galán Y, Fernández L, Torres P, García M. Trends in Cuba’s Cancer Incidence (1990 to 2003) and Mortality (1990 to 2007).MEDICC Review, Summer 2009, 11 (3): 19 -26. In http://www.medicc.org/mediccreview/index.php?issue=9&id=101&a=va [Access 31-07-2009]




2020     |     www.medigraphic.com